1. Home
  2. ELTX vs DSP Comparison

ELTX vs DSP Comparison

Compare ELTX & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$14.77

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$11.26

Market Cap

213.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
DSP
Founded
2011
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
213.3M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
ELTX
DSP
Price
$14.77
$11.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$18.00
$17.81
AVG Volume (30 Days)
126.0K
256.8K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
157.14
EPS
N/A
N/A
Revenue
$2,301,000.00
$344,201,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$16.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.00
52 Week Low
$7.37
$8.11
52 Week High
$16.00
$15.18

Technical Indicators

Market Signals
Indicator
ELTX
DSP
Relative Strength Index (RSI) 67.60 46.68
Support Level $9.76 $11.09
Resistance Level N/A $12.61
Average True Range (ATR) 1.30 0.88
MACD 0.35 -0.14
Stochastic Oscillator 79.67 16.74

Price Performance

Historical Comparison
ELTX
DSP

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.

Share on Social Networks: